Company profile: Trialbee
1.1 - Company Overview
Company description
- Provider of vendor-agnostic patient recruitment solutions for the pharmaceutical industry, featuring Honey Platform to centralize recruitment with transparency, actionable data insights and ROI reporting; Precision Recruitment using data-driven profiling, hyper-targeted digital outreach and medical secondary screening to pre-qualify clinical trial patients; and an Omnichannel Network creating diverse patient pathways via curated partners.
Products and services
- Precision Recruitment: A data-driven service that architects patient profile modeling, executes hyper-targeted digital recruitment, and conducts medical secondary screening to find and pre-qualify ideal clinical trial participants
- Honey Platform: A vendor-agnostic platform that centralizes recruitment activities and delivers transparency, actionable data insights, and ROI reporting for clinical trials
- Omnichannel Network: A curated partner network combining community engagement organizations, advocacy groups, and pharmacies to create unique patient pathways and ensure diverse recruitment in clinical trials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trialbee
Academia.edu
HQ: United States
Website
- Description: Provider of the largest and fastest-growing platform for sharing academic research, enabling academics to share research papers and aiming to accelerate and democratize academic research. Over 150 million academics have signed up, adding 25 million papers, with more than 100,000 people joining each day.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Academia.edu company profile →
Simulations Plus
HQ: United States
Website
- Description: Provider of ADMET and pharmacometric modeling software, including GastroPlus for absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics across administration routes in humans and animals; ADMET Predictor for compound property prediction; PKPlus for PK/TK analysis and reporting; DDDPlus for simulating in vitro dissolution to predict in vivo performance; DILIsym for drug-induced liver injury modeling; and MonolixSuite for NLME modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Simulations Plus company profile →
GeneFormatics
HQ: United States
Website
- Description: Provider of biotechnology specializing in structural proteomics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneFormatics company profile →
De Novo Software
HQ: United States
Website
- Description: Provider of FCS Express, the fastest-growing flow cytometry data analysis solution in the industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full De Novo Software company profile →
CCT Research
HQ: United States
Website
- Description: Provider of embedded clinical trial services, conducting Phase II–IV studies in family medicine, neurology, dermatology, and vaccines by integrating research sites into physician offices. Operates a network of over 30 sites across the US with centralized staffing, data and regulatory management, patient recruitment, investigator partnerships, and site business development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CCT Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trialbee
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trialbee
2.2 - Growth funds investing in similar companies to Trialbee
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trialbee
4.2 - Public trading comparable groups for Trialbee
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →